Return to homepagePandemic Pact

BCG-COVID-RCT: BCG vaccine to reduce absenteeism due to infectious diseases of health workers during the COVID-19 pandemic. A multi-centre randomised controlled trial

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:0 publications

Grant number: RIA2020EF-3049

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $583,727.12

  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)

  • Principal Investigator

    Prof. Christine Stabell-Benn

  • Research Location

    Guinea-Bissau, Cabo Verde

  • Lead Research Institution

    University of Southern Denmark

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Economic impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The BCG-COVID-RCT project (RIA2020EF-3049) aims to study the BCG non-specific protection of healthcare workers against COVID-19.